Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer

Keyphrases

• Dysregulation 100%
• Cholestatic Liver Injury 100%
• Liver Development 100%
• Liver Cancer 100%
• MAT1A 25%
• S-adenosylmethionine 20%
• Ursodeoxycholic Acid 20%
• Hepatocellular Carcinoma 15%
• Non-tumor Tissue 15%
• Cholestasis 15%
• Cholangiocarcinoma 15%
• Farnesoid X Receptor 15%
• Xenograft Tumor 15%
• Survival Time 10%
• Promoter Activity 10%
• Liver Tumor 10%
• Activator protein-1 (AP-1) 10%
• Nuclear factor-B 10%
• Distinct Mechanism 10%
• C-Myc 10%
• Reduced Expression 10%
• Human Cholangiocarcinoma 10%
• Quantitative PCR 5%
• Incubation 5%
• Small Interfering RNA (siRNA) 5%
• Tumor Progression 5%
• Tumor Growth 5%
• Transcription Factor 5%
• Clinical Data 5%
• China 5%
• Knockdown 5%
• Promoter Region 5%
• Overexpression 5%
• Surgical Resection 5%
• High-level Expression 5%
• Increased Activity 5%
• Immunohistochemistry 5%
• Cancer Cell Lines 5%
• Expression Level 5%
• Immunoblot 5%
• Chromatin Immunoprecipitation (ChIP) 5%
• Opposite Effects 5%
• Nude Mice 5%
• Bile Duct Ligation 5%
• Cancer Cell Proliferation 5%
• Reduced Survival 5%
• HepG2 5%
• Bile Acid Metabolism 5%
• Cancer Cell Growth 5%
• Expression Activity 5%
• E-box 5%
• Acid-promoted 5%
• HepG2 Cells 5%
• Hepatitis B 5%
• Changes in Gene Expression 5%
• Transient Transfection 5%
• S-adenosylmethionine Decarboxylase 5%
• Human Hepatocellular Carcinoma 5%
• E-box Element 5%
• Microvascular Invasion 5%
• C-Maf 5%
• Biliary Cancer 5%
• Electrophoretic Mobility Shift 5%
• Human Liver Cancer 5%
• Hep3B Cells 5%

Medicine and Dentistry

• Transcription Factors 100%
• Liver Injury 100%
• Liver Development 100%
• Liver Cancer 100%
• Cholangiocarcinoma 28%
• Promoter Region 23%
• Hepatocellular Carcinoma 19%
• S-Adenosyl Methionine 19%
• Ursodeoxycholic Acid 19%
• Neoplasm 14%
• Cholestasis 14%
• Farnesoid X Receptor 14%
• Tumor Xenograft 14%
• Tumor Progression 9%
• Liver Tumor 9%
• Survival Time 9%
• Transcription Factor AP 1 9%
• Real Time Polymerase Chain Reaction 4%
• Gene Expression 4%
• Immunohistochemistry 4%
• Cell Proliferation 4%
• Cancer Cell 4%
• Small Interfering RNA 4%
• Incubation 4%
• Upregulation 4%
• Cell Growth 4%
• Cancer Cell Line 4%
• Bile Duct Ligation 4%
• Hepatitis B 4%
• Immunoblotting 4%
• Chromatin Immunoprecipitation 4%
• Transient Transfection 4%
• Bile Duct Cancer 4%
• Surgery 4%
• Electrophoretic Mobility-Shift Assay 4%
• Lithocholic Acid 4%
• Methionine Adenosyltransferase 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Injury 100%
• Transcription Factors 100%
• Liver Cancer 100%
• Neoplasm 28%
• Bile Duct Carcinoma 28%
• Liver Cell Carcinoma 19%
• S-Adenosyl Methionine 19%
• Cholestasis 14%
• Farnesoid X Receptor 14%
• Receptor Agonist 9%
• Tumor Growth 9%
• Liver Tumor 9%
• Survival Time 9%
• Transcription Factor AP 1 9%
• Diethylnitrosamine 9%
• Malignant Neoplasm 4%
• Western Blot 4%
• Small Interfering RNA 4%
• Bile Acid 4%
• Nude Mouse 4%
• Chromatin Immunoprecipitation 4%
• Hepatitis B 4%